Literature DB >> 27171611

Expression of p16 and p53 in Intraepithelial Periocular Sebaceous Carcinoma.

W Robert Bell1, Kamaljeet Singh1, Anand Rajan Kd1, Charles G Eberhart1.   

Abstract

PURPOSE: Identifying intraepithelial sebaceous carcinoma cells in small periocular biopsies can be difficult, particularly in the conjunctiva. The goal of this study was to evaluate p53 and p16 immunohistochemistry as potential markers of intraepithelial sebaceous carcinoma. PROCEDURES: A total of 25 tumors, including 4 recurrent lesions, were stained for p16 and p53, with intensity scored as negative, weak, moderate or strong.
RESULTS: Expression of p16 was detected in intraepithelial sebaceous carcinoma cells in 24 of the 25 cases (96%), with only 1 case showing weak immunoreactivity. Intraepithelial p53 immunoreactivity was present in 17 of 25 tumors (68%), but was weak in 3 cases. Expression levels remained relatively stable in primary and recurrent tumors, but varied in a few cases between intraepithelial and subepithelial sites.
CONCLUSIONS: Intraepithelial sebaceous carcinomas stained for p53 and p16 demonstrated moderate to strong immunoreactivity in 100% of cases for at least one of these proteins, suggesting that together they are useful markers for determining the extent of tumor spread. Of the two, p16 was immunoreactive in more cases than p53.

Entities:  

Keywords:  Intraepithelial spread; Sebaceous carcinoma; p16 immunohistochemistry; p53 immunohistochemistry

Year:  2015        PMID: 27171611      PMCID: PMC4847677          DOI: 10.1159/000439308

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  14 in total

1.  Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis.

Authors:  M L KWITKO; M BONIUK; L E ZIMMERMAN
Journal:  Arch Ophthalmol       Date:  1963-06

2.  Lesions of the lids; a statistical note.

Authors:  R B WELCH; J R DUKE
Journal:  Am J Ophthalmol       Date:  1958-03       Impact factor: 5.258

3.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

4.  Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.

Authors:  Frederick A Jakobiec; Pia R Mendoza
Journal:  Am J Ophthalmol       Date:  2013-10-07       Impact factor: 5.258

5.  Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.

Authors:  Jau-Yu Liau; Shu-Lang Liao; Cheng-Hsiang Hsiao; Ming-Chieh Lin; Hsiao-Ching Chang; Kuan-Ting Kuo
Journal:  Hum Pathol       Date:  2013-10-30       Impact factor: 3.466

6.  UV-independent p53 mutations in sebaceous carcinoma of the eyelid.

Authors:  Rehan M Hussain; Jared L Matthews; Sander R Dubovy; Jordan M Thompson; Gaofeng Wang
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 Sep-Oct       Impact factor: 1.746

7.  Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.

Authors:  Namju Kim; Ji Eun Kim; Ho-Kyung Choung; Min Joung Lee; Sang In Khwarg
Journal:  Exp Eye Res       Date:  2013-11-08       Impact factor: 3.467

8.  Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.

Authors:  Kunihiro Kiyosaki; Chisato Nakada; Naoki Hijiya; Yoshiyuki Tsukamoto; Keiko Matsuura; Kazuo Nakatsuka; Tsutomu Daa; Shigeo Yokoyama; Masamoto Imaizumi; Masatsugu Moriyama
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

9.  Sebaceous gland carcinoma. Review of 40 cases.

Authors:  M T Doxanas; W R Green
Journal:  Arch Ophthalmol       Date:  1984-02

10.  Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.

Authors:  Z P Ren; F Pontén; M Nistér; J Pontén
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

View more
  5 in total

1.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

2.  Regression of Sebaceous Carcinoma of the Eyelid after a Small Incisional Biopsy: Report of Two Cases.

Authors:  Seymour Brownstein; Sonul Mehta; Navdeep Nijhawan; Guy Allaire; Tuan Quynh Tram Nguyen; Tina Tang; Kailun Jiang; Solin Saleh; Evan Kalin-Hajdu; Robbin Bruen; James Oestrelcher
Journal:  Ocul Oncol Pathol       Date:  2018-11-02

Review 3.  Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature.

Authors:  Yangfan Xu; Fang Li; Renbing Jia; Xianqun Fan
Journal:  Onco Targets Ther       Date:  2018-06-27       Impact factor: 4.147

4.  Sebaceous Gland Carcinoma with Misleading Clinical Appearance: A Case Report of an Eyelid Lesion.

Authors:  Hala A Helmi; Waleed Alsarhani; Hind Manaa Alkatan; Ammar C Al-Rikabi; Yasser H Al-Faky
Journal:  Am J Case Rep       Date:  2020-08-13

5.  Bioinformatics analysis of the microRNA-mRNA network in sebaceous gland carcinoma of the eyelid.

Authors:  Tetsushi Hirano; Tatsuya Yunoki; Yukihiro Furusawa; Yoshiaki Tabuchi; Atsushi Hayashi
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.